| NCT ID | NCT07232940 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bursa City Hospital |
| Condition | Video-assisted Thoracoscopic Surgery (VATS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-11-15 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-11-15 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Video-assisted thoracoscopic surgery (VATS) is a minimally invasive procedure performed through small thoracic incisions, but postoperative pain remains significant due to tissue and rib trauma. Poorly controlled pain may lead to chronic postoperative pain; therefore, optimal analgesia is essential. According to PROSPECT guidelines, erector spinae plane block (ESPB) or paravertebral block (PVB) are recommended for VATS. The recently defined serratus posterior superior intercostal plane block (SPSIPB) provides analgesia between C3-T10 levels, but its efficacy compared with ESPB has not been studied. This study aims to compare postoperative analgesic efficacy and patient satisfaction between ESPB and SPSIPB in VATS patients.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-65 years with ASA physical status I-III who will undergo elective video-assisted thoracoscopic surgery (VATS) will be included. Exclusion Criteria: * Patients who do not consent to participate in the study Patients with coagulopathy Patients with a history of local anesthetic allergy or toxicity Patients with hepatic or renal failure Patients with uncontrolled diabetes Patients with uncontrolled hypertension Mentally disabled patients Patients receiving chronic pain treatment (opioid users) Patients using antidepressant medication Patients with neuropathic pain Mentally disabled patients Presence of infection at the injection site Pregnant or breastfeeding women, or those with suspected pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07232940 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Video-assisted Thoracoscopic Surgery (VATS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07232940 currently recruiting?
Yes, NCT07232940 is actively recruiting participants. Contact the research team at eralpcevikkalp@hotmail.com for enrollment information.
Where is the NCT07232940 trial being conducted?
This trial is being conducted at Bursa, Turkey (Türkiye).
Who is sponsoring the NCT07232940 clinical trial?
NCT07232940 is sponsored by Bursa City Hospital. The trial plans to enroll 90 participants.